These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6458299)

  • 1. The incorporation of 5-fluoro-2'-deoxyuridine into DNA of mammalian tumor cells.
    Danenberg PV; Heidelberger C; Mulkins MA; Peterson AR
    Biochem Biophys Res Commun; 1981 Sep; 102(2):654-8. PubMed ID: 6458299
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-Fluoro-2'-deoxyuridine incorporation in L1210 DNA.
    Kufe DW; Major PP; Egan EM; Loh E
    J Biol Chem; 1981 Sep; 256(17):8885-8. PubMed ID: 6455432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity of 5-fluoro-5'-O-nitro-2'-deoxyuridine, a new fluorinated pyrimidine derivative, in L1210 cultures.
    Roberts D; Franklin P; Odom G; Peck C; Chwang TL
    Mol Pharmacol; 1982 Nov; 22(3):760-5. PubMed ID: 6218391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Fluoro-5'-deoxyuridine is an inhibitor of uridylate nucleotidase in L1210 leukaemia.
    Roobol C; De Dobbeleer GB; Bernheim JL
    Adv Exp Med Biol; 1986; 195 Pt B():177-83. PubMed ID: 3020904
    [No Abstract]   [Full Text] [Related]  

  • 5. Biologic effect of 5-fluoro-2'-deoxyuridine incorporation in L1210 deoxyribonucleic acid.
    Kufe DW; Scott P; Fram R; Major P
    Biochem Pharmacol; 1983 Apr; 32(8):1337-40. PubMed ID: 6190482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-fluorouracil and 5-fluoro-2'-deoxyuridine follow different metabolic pathways in the induction of cell lethality in L1210 leukaemia.
    Roobol C; De Dobbeleer GB; Bernheim JL
    Br J Cancer; 1984 Jun; 49(6):739-44. PubMed ID: 6234011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporation of iododeoxyuridine-125-I into the DNA of L1210 leukemia cells during tumor development.
    Her KG; Hughes WL
    Cancer Res; 1970 Jan; 30(1):236-43. PubMed ID: 5458962
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction of thymidylate synthetase and dihydrofolate reductase enzymes in vitro and in vivo.
    Kawai M; Hillcoat BL
    Cancer Res; 1974 Jul; 34(7):1619-26. PubMed ID: 4833915
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies.
    Jackman AL; Alison DL; Calvert AH; Harrap KR
    Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo effects of methotrexate. Inhibition of DNA synthesis and cell death in sensitive and resistant L1210 ascites populations.
    Hofer KG
    Chemotherapy; 1972; 17(1):59-70. PubMed ID: 5009468
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation of thymidylate synthetase in mouse leukemia cells (L1210).
    Rode W; Scanlon KJ; Moroson BA; Bertino JR
    J Biol Chem; 1980 Feb; 255(4):1305-11. PubMed ID: 6965493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymidine inhibits the incorporation of 5-fluoro-2'-deoxyuridine to DNA of mouse mammary tumour.
    Nayak R
    Biochem Biophys Res Commun; 1992 Apr; 184(1):467-70. PubMed ID: 1533124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of thymidylate synthetase in the cytostatic activity of pyrimidine nucleoside analogues.
    Balzarini J
    Bull Mem Acad R Med Belg; 1985; 140(11):432-40. PubMed ID: 3841831
    [No Abstract]   [Full Text] [Related]  

  • 14. Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissues.
    Chabner BA; Young RC
    J Clin Invest; 1973 Aug; 52(8):1804-11. PubMed ID: 4719662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 1,3-bis(2-chloroethyl)-1-nitrosourea on newly synthesized DNA in L-1210 cells.
    Tashima M; Sawada H; Tatsumi K; Nakamura T; Uchino H
    Biochem Pharmacol; 1979; 28(4):511-7. PubMed ID: 426871
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism of the cytotoxic synergism of fluoropyrimidines and folinic acid in mouse leukemic cells.
    Keyomarsi K; Moran RG
    J Biol Chem; 1988 Oct; 263(28):14402-9. PubMed ID: 2971656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymidylate synthetase - a target enzyme in cancer chemotherapy.
    Danenberg PV
    Biochim Biophys Acta; 1977 Dec; 473(2):73-92. PubMed ID: 145246
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative physiologic dispositions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil in mice bearing solid L1210 lymphocytic leukemia.
    Chadwick M; Chang C
    Cancer Treat Rep; 1976 Jul; 60(7):845-55. PubMed ID: 137772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific metabolic changes in DNA-treated L1210 leukemia cells.
    Glick JL; Sahler C
    Cancer Res; 1967 Dec; 27(12):2342-9. PubMed ID: 4230120
    [No Abstract]   [Full Text] [Related]  

  • 20. Suicide prodrugs activated by thymidylate synthase: rationale for treatment and noninvasive imaging of tumors with deoxyuridine analogues.
    Collins JM; Klecker RW; Katki AG
    Clin Cancer Res; 1999 Aug; 5(8):1976-81. PubMed ID: 10473074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.